Vineeth Varanasi

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

Vineeth Varanasi, Anit Singh, Marcela F. Pasetti et al. · Clinical Infectious Diseases · 2015 · 199 citations · Full text

Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses

Anita Garg Mangla, Anupriya Khare, Vineeth Varanasi et al. · Blood · 2004 · 130 citations · Full text

NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses

Andrew Zloza, Frederick J. Kohlhapp, Gretchen E. Lyons et al. · Nature Medicine · 2012 · 65 citations

Signal Transduction, Immunology, Autoimmunity +9

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau et al. · The Lancet · 2023 · 58 citations

Rheumatology, Clinical Trials, Clinical Dermatology +5

Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen

Nitin Tupperwar, Vineeth Varanasi, Satyajit Rath et al. · Diagnostic Microbiology and Infectious Disease · 2008 · 56 citations

Parasitic Disease, Parasitic Protozoa, Bioanalysis +8